Trading News

China Cash Flowed Through Congo Bank to Former President’s Cronies



Shkreli, former company ask judge to find no wrongdoing in Daraprim lawsuit

WASHINGTON (Reuters) -Martin Shkreli, in jail on an unrelated matter, his former company Vyera Pharmaceuticals and others asked a judge Monday to find that they broke no laws in their handling of the drug Daraprim, which saw its price increase by more than 4,000% in one day. The Federal Trade Commission filed a lawsuit in January 2020, alleging that the company that Shkreli once ran protected its dominance of the drug by restricting distribution to ensure generic drug makers could not get the samples needed to bring out a cheaper version of the drug. The company, formerly Turing Pharmaceuticals, also prevented potential competitors from buying an ingredient, the FTC said.

Amazon warehouse workers in Alabama will get another chance to vote to unionize

Previous article

3 “Strong Buy” Stocks for Bottom-Fishing Investors

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Trading News